{"cdcTestId":"2020-0022","testcaseName":"Dose #1 of Pfizer Covid-19 Vaccine (age 12 years)","vaccineGroup":"COVID-19","evaluationTestType":"All Valid: Forecast Test","forecastTestType":"Recommended based on interval","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2010-10-19T00:00:00","gender":"M"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"208","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"2","earliestDate":"2022-11-09T00:00:00","recommendedDate":"2022-11-09T00:00:00","pastDueDate":"2022-12-13T00:00:00"},"doses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"Pfizer-BioNTech COVID-19 Vaccine (EUA labeled)  COMIRNATY (BLA labeled)","cvx":"208","mvx":"PFR","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2020-10-06T20:00:00","dateUpdated":"2022-03-02T13:27:57.136","generalDescription":"This test case describes when a patient is administered the first dose of the Pfizer Covid-19 vaccine (at age 12 years), that the dose is valid.  Another dose should be forecast.","changedInVersion":"4.21","reasonForChange":"v4.21 Updated past due date to 8 weeks per 02/22/22 Clinical Considerations guidelines\nv4.8 Changed age of patient from 16 to 12 years based on new ACIP guidelines for Pfizer vaccine eligibility.\nv4.6 Added latest recommended interval."}